Vertex Pharmaceuticals Incorporated logo

Vertex Pharmaceuticals Incorporated

NASDAQ:VRTX

Overview | Financials
Company Name Vertex Pharmaceuticals Incorporated
Symbol VRTX
Currency USD
Price 395.25
Market Cap 101,338,542,750
Dividend Yield 0%
52-week-range 362.5 - 519.88
Industry Biotechnology
Sector Healthcare
CEO Dr. Reshma Kewalramani FASN, M.D.
Website https://www.vrtx.com

An error occurred while fetching data.

About Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAFTA for the treatment of patients with CF

Related Stocks

Regeneron Pharmaceuticals, Inc. logo

Regeneron Pharmaceuticals, Inc.

REGN

558.44 USD

Intuitive Surgical, Inc. logo

Intuitive Surgical, Inc.

ISRG

470 USD

Gilead Sciences, Inc. logo

Gilead Sciences, Inc.

GILD

115.88 USD

Moderna, Inc. logo

Moderna, Inc.

MRNA

24.83 USD

Illumina, Inc. logo

Illumina, Inc.

ILMN

98.18 USD

Walgreens Boots Alliance, Inc. logo

Walgreens Boots Alliance, Inc.

WBA

11.98 USD

IDEXX Laboratories, Inc. logo

IDEXX Laboratories, Inc.

IDXX

652.83 USD

Biogen Inc. logo

Biogen Inc.

BIIB

141.35 USD

Financials

Numbers are in millions USD

Numbers are in millions USD